New ANDA Cases

Summer 2016

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Alembic Pharms. Ltd. v. Daiichi Sankyo Co., Ltd., 16-3956 (N.D. Ill.) Apr. 1, 2016 Hon. John Z. Lee Benicar® (olmesartan medoxomil tablets) 6,878,703
Merck Sharp & Dohme Corp. v. Roxane Labs., Inc., 16-0285 (S.D. Ohio) Apr. 1, 2016 Hon. James L. Graham Noxafil® (posaconazole oral suspension)
5,661,151
6,958,337
Warner Chilcott (US), LLC v. Zydus Pharms. (USA) Inc., 16-0323 (E.D. Tex.) Apr. 1, 2016 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00829 (PTAB) Apr. 1, 2016 N/A Ravicti® (glycerol phenylbutyrate oral solution) 9.095.559
Millennium Pharms., Inc. v. Actavis LLC, 16-0223 (D. Del.) Apr. 4, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446
Javelin Pharms., Inc. v. Mylan Labs. Ltd., 16-0224 (D. Del.) Apr. 4, 2016 Hon. Leonard P. Stark Dyloject® (diclofenac sodium for injection)
6,407,079
8,946,292
Abraxis Bioscience, LLC v. Actavis LLC, 16-1925 (D.N.J.) Apr. 6, 2016 Hon. John Michael Vazquez Abraxane® (albumin-bound paclitaxel for injection)
7,820,788
7,923,536
8,138,229
8,853,260
Javelin Pharms., Inc. v. Mylan Labs. Ltd., 16-0059 (N.D.W.V.) Apr. 6, 2016 Hon. Irene M. Keeley Dyloject® (diclofenac sodium for injection)
6,407,079
8,946,292
Acura Pharms., Inc. v. Purdue Pharma L.P., IPR2016-00849 (PTAB) Apr. 6, 2016 N/A OxyContin® (oxycodone tablets) 8,389,007
Fresenius Kabi USA, LLC v. Maia Pharms., Inc., 16-0237 (D. Del.) Apr. 7, 2016 Hon. Gregory M. Sleet Levothyroxine Sodium (levothyroxine sodium for injection)
9,006,289
9,168,238
9,168,239
Alcon Research, Ltd. v. Watson Labs., Inc., 16-0238 (D. Del.) Apr. 7, 2016 Hon. Richard G. Andrews Izba® (travoprost ophthalmic solution)
8,178,582
8,722,735
8,754,123
9,144,561
AstraZeneca Pharms. LP v. InnoPharma Licensing LLC, 16-1962 (D.N.J.) Apr. 7, 2016 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Bayer Intellectual Property GMBH v. Micro Labs Ltd., 16-0242 (D. Del.) Apr. 8, 2016 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,585,860
7,592,339
Takeda Pharm. Co. Ltd. v. Teva Pharms. USA, Inc., 16-0246 (D. Del.) Apr. 8, 2016 Hon. Leonard P. Stark Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Upsher-Smith Labs., Inc. v. Zydus Pharms. (USA) Inc., 16-0248 (D. Del.) Apr. 8, 2016 Hon. Sue L. Robinson Qudexy® XR (topiramate extended-release capsules)
8,652,527
8,889,190
9,101,545
Fresenius Kabi USA, LLC v. B. Braun Medical Inc., 16-0250 (D. Del.) Apr. 11, 2016 Hon. Richard G. Andrews Diprivan® (propofol for injection) 8,476,010
Allergan, Inc. v. Famy Care Ltd., 16-0401 (E.D. Tex.) Apr. 12, 2016 Hon. Rodney Gilstrap Restasis® (cyclosporine ophthalmic emulsion)
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
Takeda GMBH v. Torrent Pharma Inc., 16-1280 (D.N.J.) Apr. 13, 2016 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
Galderma Labs., L.P. v. Akorn, Inc., 16-1012 (N.D. Tex.) Apr. 14, 2016 Hon. David C Godbey Clobex® (clobetasol propionate spray) 5,972,920
Forest Labs., LLC v. Apotex Corp., 16-0269 (D. Del.) Apr. 15, 2016 Hon. Gregory M. Sleet Teflaro® (ceftaroline fosamil injection) 6,417,175
Teva Pharms. USA, Inc. v. Biocon Ltd., 16-0278 (D. Del.) Apr. 19, 2016 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate injection)
8,232,250
8,399,413
8,969,302
9,155,776
Sanofi-Aventis U.S. LLC v. Dr. Reddy's Labs., Inc., 16-2259 (D.N.J.) Apr. 21, 2016 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel solution for infusion) 5,847,170
Novartis AG v. Mylan Pharms. Inc., 16-0289 (D. Del.) Apr. 22, 2016 Hon. Leonard P. Stark Gilenya® (fingolimod capsules) 5,604,229
Senju Pharm. Co., Ltd. v. Hi-tech Pharmacal Co., Inc., 16-2270 (D.N.J.) Apr. 22, 2016 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
9,144,609
Par Pharm., Inc. v. Luitpold Pharms., Inc., 16-2290 (D.N.J.) Apr. 22, 2016 Hon. William H. Walls Adrenalin® (epinephrine injection)
9,119,876
9,295,657
Par Pharm., Inc. v. Luitpold Pharms., Inc., 16-1999 (E.D.N.Y.) Apr. 22, 2016 Hon. Ann M Donnelly Adrenalin® (epinephrine injection)
9,119,876
9,295,657
Galderma Labs., L.P. v. Tolmar Inc., 16-1099 (N.D. Tex.) Apr. 22, 2016 Hon. David C Godbey Epiduo® (adapalene and benzoyl peroxide gel)
8,071,644
8,080,537
8,129,362
8,445,543
8,809,305
Amneal Pharms. LLC v. GlaxoSmithKline LLC, 16-0300 (D. Del.) Apr. 25, 2016 Hon. Sue L. Robinson Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Boehringer Ingelheim Pharma GMBH & Co. KG v. Hetero USA, Inc., 16-2356 (D.N.J.) Apr. 26, 2016 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Boehringer Ingelheim Pharms. Inc. v. Dr. Reddy's Labs., Ltd., 16-2394 (D.N.J.) Apr. 28, 2016 Hon. Peter G. Sheridan
Tradjenta® (linagliptin tablets)
 
Jentadueto® (linagliptin / metformin hydrochloride tablets)
9,173,859
AstraZeneca AB v. Hetero USA Inc., 16-2442 (D.N.J.) Apr. 29, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Aurobindo Pharms. Ltd. v. Daiichi Sankyo, Inc., 16-4876 (N.D. Ill.) May 2, 2016 Hon. Rebecca R. Pallmeyer
Benicar® (olmesartan medoxomil tablets)
 
Benicar HZT® (olmesartan medoxomil / hydrochlorothiazide tablets)
6,878,703
BTG International Ltd. v. Amerigen Pharms., Inc., 16-2449 (D.N.J.) May 2, 2016 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-2475 (D.N.J.) May 2, 2016 Hon. Jerome B. Simandle, Abilify® (aripiprazole tablets) 8,759,350
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-2476 (D.N.J.) May 2, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Endo Pharms. Inc. v. Impax Labs., Inc., 16-2526 (D.N.J.) May 4, 2016 Hon. Jose L. Linares Opana® ER (extended-release oxymorphone hydrochloride)
8,309,122
8,329,216
8,808,737
Leo Pharma A/S v. Actavis Labs. UT, Inc., 16-0333 (D. Del.) May 6, 2016 Hon. Sue L. Robinson Picato® (ingenol mebutate gel)
7,410,656
8,278,292
8,372,827
8,372,828
8,377,919
8,536,163
8,716,271
8,735,375
AstraZeneca LP v. Watson Labs., Inc., 16-0338 May 9, 2016 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,525,060
7,250,419
7,265,124
Breckenridge Pharm., Inc. v. Novartis AG, IPR2016-01023 (PTAB) May 10, 2016 N/A
Zortress® (everolimus tablets)
 
Afinitor® (everolimus tablets)
 
Afinitor® Disperz (everolimus oral suspension)
5,665,772
Rhodes Pharms. L.P. v. Actavis, Inc., 16-2667 (D.N.J.) May 11, 2016 Hon. William H. Walls Aptensio XR® (methylphenidate hydrochloride extended-release capsules)
6,419,960
7,083,808
7,247,318
7,438,930
8,580,310
9,066,869
Mylan Institutional LLC v. Aurobindo Pharma Ltd., 16-0491 (E.D. Tex.) May 11, 2016 Hon. Robert W. Schroeder, III Isosulfan blue (isosulfan blue)
7,662,992
8,969,616
Amneal Pharma. LLC v. Purdue Pharma L.P., IPR2016-01027 (PTAB) May 11, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976
Amneal Pharma. LLC v. Purdue Pharma L.P., IPR2016-01028 (PTAB) May 11, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976
Wockhardt Bio AG v. AstraZeneca AB, IPR2016-01029 (PTAB) May 11, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)
 
Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Mylan Pharms Inc. v. Shire Labs., Inc., IPR2016-01033 (PTAB) May 12, 2016 N/A Adderall® XR (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE42,096
Santen Pharm. Co., Ltd. v. Micro Labs Ltd., 16-0353 (D. Del.) May 13, 2016 Hon. Gregory M. Sleet Zioptan® (tafluprost ophthalmic solution) 5,886,035
Santen Pharm. Co., Ltd. v. Sandoz Inc., 16-0354 (D. Del.) May 13, 2016 Hon. Gregory M. Sleet Zioptan® (tafluprost ophthalmic solution) 5,886,035
Par Pharm., Inc. v. Novartis AG, IPR2016-01059 (PTAB) May 17, 2016 N/A
Zortress® (everolimus tablets)
 
Afinitor® (everolimus tablets)
 
Afinitor® Disperz (everolimus oral suspension)
5,665,772
ApoPharma Inc. v. Taro Pharm. Indus., Ltd., 16-0528 (E.D. Tex.) May 18, 2016 Hon. Robert W. Schroeder, III Ferriprox® (deferiprone tablets) 7,049,328
Novartis AG v. Mylan Pharms. Inc., 16-0093 (N.D.W.V.) May 18, 2016 Hon. Irene M. Keeley Gilenya® (fingolimod capsules) 5,604,229
Forest Labs., LLC v. Accord Healthcare, Inc., 16-0375 (D. Del.) May 20, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules)
8,039,009
8,058,291
8,168,209
8,173,708
8,283,379
8,293,794
8,329,752
8,338,485
8,338,486
8,362,085
8,580,858
8,598,233
Lotus Pharm. Co., Ltd. v. GlaxoSmithKline LLC, 16-0377 (D. Del.) May 20, 2016 Hon. Gregory M. Sleet Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Mylan Pharms., Inc. v. Research Corp. Technologies, Inc., IPR2016-01101 (PTAB) May 25, 2016 N/A Vimpat® (lacosamide) RE38,551
Allergan, Inc. v. Somerset Therapeutics, LLC, 16-0392 (D. Del.) May 26, 2016 Hon. Gregory M. Sleet Lastacaft® (alcaftadine ophthalmic solution) 8,664,215
Roxane Labs., Inc. v. Novartis AG, IPR2016-01102 (PTAB) May 26, 2016 N/A
Zortress® (everolimus tablets)
 
Afinitor® (everolimus tablets)
 
Afinitor® Disperz (everolimus oral suspension)
5,665,772
Breckenridge Pharm., Inc. v. Novartis AG, IPR2016-01103 (PTAB) May 26, 2016 N/A
Zortress® (everolimus tablets)
 
Afinitor® (everolimus tablets)
 
Afinitor® Disperz (everolimus oral suspension)
5,665,772
Alvogen Pine Brook LLC v. Noven Pharms., Inc., 16-0395 May 27, 2016 Hon. Leonard P. Stark Minivelle® (estradiol extended-release film)
6,841,716
8,231,906
Orexo AB v. Actavis Elizabeth LLC, 16-0397 (D. Del.) May 27, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride sublingual tablets) 9,259,421
AbbVie Inc. v. Amneal Pharms., LLC, 16-0398 (D. Del.) May 27, 2016 Hon. Richard G. Andrews Norvir® (ritonavir tablets)
7,148,359
7,364,752
Luye Pharma Group Ltd. v. Alkermes Pharma Ireland Ltd, IPR2016-01095 (PTAB) May 31, 2016 N/A
Bydureon® (exenatide synthetic extended-release suspension)
 
Vivitrol® (naltrexone extended-release suspension)
 
Risperdal® (risperidone for injection)
6,667,061
Luye Pharma Group Ltd. v. Alkermes Pharma Ireland Ltd, IPR2016-01096 (PTAB) May 31, 2016 N/A
Bydureon® (exenatide synthetic extended-release suspension)
 
Vivitrol® (naltrexone extended-release suspension)
 
Risperdal® (risperidone for injection)
6,667,061
Dr. Reddyy's Labs., Ltd v. MonoSol RX, LLC, IPR2016-01111 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,603,514
Dr. Reddyy's Labs., Ltd v. MonoSol RX, LLC, IPR2016-01112 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,017,150
Dr. Reddyy's Labs., Ltd v. Indivior UK Limited f/k/a RB Pharms. Ltd., IPR2016-01113 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,475,832
Sun Pharm. Indus., Ltd. v. AstraZeneca AB, IPR2016-01104 (PTAB) June 1, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)
 
Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Teva Pharms. USA, Inc. v. AstraZeneca AB, IPR2016-01122 (PTAB) June 1, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)
 
Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Aurobindo Pharma U.S.A., Inc. v. AstraZeneca AB, IPR2016-01117 (PTAB) June 2, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)
 
Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01127 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,685,930
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01128 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,629,111
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01129 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,642,556
Mylan Pharms. Inc. v. Allergan, Inc., IR2016-01130 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,633,162
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01131 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,648,048
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01132 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 9,248,191
Mylan Pharms., Inc. v. Senju Pharm. Co., Ltd., IPR2016-01163 (PTAB) June 8, 2016 N/A Bepreve® (bepotastine besilate ophthalmic solution) 8,877,168
Aurobindo Pharma USA Inc. v. Apicore US LLC, 16-3358 (D.N.J.) June 9, 2016 Hon. Renee Marie Bumb Isosulfan blue (isosulfan blue)
7,662,992
8,969,616
9,353,050
Leo Pharma A/S v. Perrigo UK Finco Ltd. Partnership, 16-0430 (D. Del.) June 10, 2016 Hon. Sue L. Robinson Picato® (ingenol mebutate gel)
6,432,452
6,787,161
6,844,013
7,410,656
8,278,292
8,372,827
8,372,828
8,377,919
8,536,163
8,716,271
8,735,375
Novartis Pharms. Corp. v. Breckenridge Pharm., Inc., 16-0431 (D. Del.) June 10, 2016 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
8,410,131
8,778,962
Purdue Pharma L. P. v. Collegium Pharm., Inc., 16-11091 (D. Mass.) June 10, 2016 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone)
 
Xtampza ER™ (oxycodone)
9,155,717
UCB, Inc. v. Aurobindo Pharma Ltd., 16-0451 (D. Del.) June 17, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide) RE38,551
UCB, Inc. v. Hetero USA Inc., 16-0452 (D. Del.) June 17, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide) RE38,551
Shire Orphan Therapies LLC v. InnoPharma, Inc., 16-0456 (D. Del.) June 17, 2016 Hon. Gregory M. Sleet Firazyr® (icatibant for injection) 5,648,333
United Therapeutics Corp. v. Actavis Labs. FL, Inc., 16-3642 (D.N.J.) June 17, 2016 Hon. Peter G. Sheridan Orenitram® (treprostinil extended-release tablets)
7,417,070
7,544,713
8,252,839
8,349,892
8,410,169
8,497,393
9,050,311
8,747,897
9,278,901
Noven Pharms., Inc. v. Actavis Labs. UT, Inc., 16-0465 (D. Del.) June 20, 2016 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system) 8,231,906
Eli Lilly and Co. v. Apotex Inc., 16-1512 (S.D. Ind.) June 20, 2016 Hon. William T. Lawrence Axiron® (testosterone metered transdermal solution)
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
9,180,194
9,289,586
Breckenridge Pharm., Inc. v. Research Corp. Technologies, Inc., IPR2016-01242 (PTAB) June 21, 2016 N/A Vimpat® (lacosamide) RE38,551
Eli Lilly and Co. v. Apotex Inc., 16-0475 (D. Del.) June 22, 2016 Hon. Leonard P. Stark Axiron® (testosterone metered transdermal solution)
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
9,180,194
9,289,586
Argentum Pharms. LLC v. Allergan, Inc., IPR2016-01232 (PTAB) June 22, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,629,111
Alembic Pharms., Ltd.v. Research Corp. Technologies, Inc., IPR2016-01245 (PTAB) June 22, 2016 N/A Vimpat® (lacosamide) RE38,551
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd., 16-3722 (D.N.J.) June 23, 2016 Hon. Renee Marie Bumb Emtriva® (emtricitabine capsules)
6,642,245
6,703,396
Mylan Pharms., Inc. v. Research Corp. Technologies, Inc., IPR2016-01248 (PTAB) June 23, 2016 N/A Vimpat® (lacosamide) RE38,551
BTG Int'l Ltd. v. Glenmark Pharms. Inc., USA, 16-3743 (D.N.J.) June 24, 2016 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Apotex Inc. v. Osi Pharms., Inc., IPR2016-01284 (PTAB) June 28, 2016 N/A Tarceva® (erlotinib hydrochloride tablets) 6,900,221
Genzyme Corp. v. Zydus Pharms. (USA) Inc., 16-0540 (D. Del.) June 29, 2016 Hon. Gregory M. Sleet Mozobil® (plerixafor for injection)
7,897,590
6,987,102
Janssen Pharmaceutica N.V. v. Xellia Pharms ApS, 16-0554 (D. Del.) June 29, 2016 Hon. Leonard P. Stark Sporanox® (voriconazole for injection) 6,407,079
Genzyme Corp. v. Amneal Pharms. LLC, 16-3892 (D.N.J.) June 29, 2016 Hon. Stanley R. Chesler Clolar® (clofarabine for injection) 5,661,136
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01316 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 6,774,122
Argentum Pharms. LLC v. Janssen Oncology, Inc., IPR2016-01317 (PTAB) June 29, 2016 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01324 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 7,456,160
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01325 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 8,329,680
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01326 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 8,466,139
Alcon Pharms. Ltd. v. Imprimis Pharms., Inc., 16-0563 (D. Del.) June 30, 2016 Hon. Sue L. Robinson Vigamox® (moxifloxacin hydrochloride ophthalmic solution)
6,716,830
7,671,070
Genzyme Corp. v. Zydus Pharms. (USA) Inc., 16-3905 (D.N.J.) June 30, 2016 Hon. Renee Marie Bumb Mozobil® (plerixafor for injection)
7,897,590
6,987,102
Horizon Therapeutics, Inc. v. Par Pharm., Inc., 16-3910 (D.N.J.) June 30, 2016 Hon. Robert B. Kugler Ravicti® (glycerol phenylbutyrate oral solution)
9,095,559
9,254,278
9,326,966
Mylan Pharms., Inc. v. Janssen Oncology, Inc., IPR2016-01332 (PTAB) June 30, 2016 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Wockhardt Bio AG v. Eli Lilly and Co., IPR2016-01335 (PTAB) June 30, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Wockhardt Bio AG v. Eli Lilly and Co., IPR2016-01337 (PTAB) June 30, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Back to Top